| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.0022 |
0.9 |